drugset / Trial / NCT02794506

Propolis Improves Glycemic Control in Subjects With Type 2 Diabetes and Chronic Periodontitis

NCT02794506

Phase 4 Completed 52 enrolled Mohamed Anees Mansoura University · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

Background: Propolis is a natural resin made by bees from various plant sources. Propolis exerts antimicrobial, anti-inflammatory, immunomodulatory, antioxidant, and antidiabetic properties. The purpose of this study was to assess the adjunctive benefit of propolis supplementation in individuals with both chronic periodontitis and type 2 diabetes mellitus (T2DM) receiving scaling and root planing (SRP). Methods: A 6-month randomized blinded clinical trial comparing SRP with placebo (placebo+SRP group, n=26) or combined with a 6- month regimen of 400 mg oral propolis once daily (propolis+SRP group, n=26) was performed in patients with long-standing T2DM and chronic periodontitis. Treatment outcomes included hemoglobin A1c (HbA1c), fasting plasma glucose (FPG), serum N€-(carboxymethyl) lysine (CML) and changes in periodontal parameters.

Timeline

Start
2014-06
Primary completion
2014-12
Completion
2015-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject PROPOLIS WAX Traditional medicine (herbal / TCM) 400 mg